This increase reflects continued efforts by the Canadian government to secure access to safe and effective COVID-19 vaccines for Canadian citizens.
On December 23, Health Canada authorized the COVID-19 Vaccine Moderna for the immunization of people 18 years of age and older under an Interim Order.
Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2 vaccine) is indicated for active immunization against coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus in individuals 18 years of age and older.
Moderna is advancing messenger RNA science to create a new class of transformative medicines for patients.
mRNA medicines are designed to direct the body's cells to produce intracellular, membrane or secreted proteins that can have a therapeutic or preventive benefit and have the potential to address a broad spectrum of diseases.
The company's platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, providing Moderna the capability to pursue in parallel a robust pipeline of new development candidates.
Moderna is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune and inflammatory diseases, independently and with strategic collaborators.
Headquartered in Cambridge, Mass., Moderna currently has strategic alliances for development programs with AstraZeneca plc (OTC: AZNCF) and US-based Merck and Co., Inc. (NYSE: MRK), as well as the Defense Advanced Research Projects Agency (DARPA), an agency of the US Department of Defense, and Barda.
Moderna has been named a top biopharmaceutical employer by Science for the past six years.
Beck Named Chief Financial Officer at 4D Pharma
Gyroscope Therapeutics names Jessica Stitt as CFO
Mind Medicine acquires HealthMode
Campanelli Named to Slayback Board of Directors
Zhang Named Chief Medical Officer at InnoCare
Neuvogen appoints new director
WuXi Biologics receives 2021 CMO Leadership Awards
The University of Health Sciences and Pharmacy in St Louis names new president